News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
HOFFMANN DAVE
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/18/2020 |
4
| HOFFMANN DAVE (Director) has filed a Form 4 on DURECT CORP
Txns:
| Granted 55,000 options to buy
@ $2.33, valued at
$128.2k
|
|
06/01/2020 |
4
| HOFFMANN DAVE (Director) has filed a Form 4 on Molecular Templates, Inc.
Txns:
| Granted 15,000 options to buy
@ $15.43, valued at
$231.5k
|
|
06/20/2019 |
4
| HOFFMANN DAVE (Director) has filed a Form 4 on DURECT CORP
Txns:
| Granted 55,000 options to buy
@ $0.5818, valued at
$32k
|
|
05/30/2019 |
4
| HOFFMANN DAVE (Director) has filed a Form 4 on Molecular Templates, Inc.
Txns:
| Granted 15,000 options to buy
@ $8.21, valued at
$123.2k
|
|
06/20/2018 |
4
| HOFFMANN DAVE (Director) has filed a Form 4 on DURECT CORP
Txns:
| Granted 55,000 options to buy
@ $2.1, valued at
$115.5k
|
|
06/04/2018 |
4
| HOFFMANN DAVE (Director) has filed a Form 4 on Molecular Templates, Inc.
Txns:
| Granted 15,000 options to buy
@ $6.31, valued at
$94.7k
|
|
10/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/28/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/28/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/04/2016 |
4
| HOFFMANN DAVE (Director) has filed a Form 4 on DURECT CORP
Txns:
| Granted 36,058 options to buy
@ $1.35, valued at
$48.7k
|
|
06/26/2013 |
4
| HOFFMANN DAVE (Director) has filed a Form 4 on DURECT CORP
Txns:
| Granted 35,000 options to buy
@ $1.05, valued at
$36.8k
|
|
06/21/2012 |
4
| HOFFMANN DAVE (Director) has filed a Form 4 on DURECT CORP
Txns:
| Granted 25,000 options to buy
@ $0.8198, valued at
$20.5k
|
|
05/21/2012 |
4
| HOFFMANN DAVE (Director) has filed a Form 4 on THRESHOLD PHARMACEUTICALS INC
Txns:
| Granted 20,000 options to buy
@ $6.39, valued at
$127.8k
|
|
05/14/2012 |
4
| HOFFMANN DAVE (Director) has filed a Form 4 on DURECT CORP
Txns:
| Bought 300 shares
@ $0.7925, valued at
$237.8 Bought 1,867 shares
@ $0.795, valued at
$1.5k
Bought 300 shares
@ $0.7998, valued at
$239.9 Bought 7,533 shares
@ $0.8, valued at
$6k
Bought 200 shares
@ $0.7999, valued at
$160 Bought 4,367 shares
@ $0.8, valued at
$3.5k
Bought 300 shares
@ $0.81, valued at
$243 Bought 5,158 shares
@ $0.82, valued at
$4.2k
Bought 4,600 shares
@ $0.828, valued at
$3.8k
Bought 375 shares
@ $0.83, valued at
$311.3 |
|
06/24/2011 |
4
| HOFFMANN DAVE (Director) has filed a Form 4 on DURECT CORP
Txns:
| Granted 25,000 options to buy
@ $3.09, valued at
$77.3k
|
|
06/24/2010 |
4
| HOFFMANN DAVE (Director) has filed a Form 4 on DURECT CORP
Txns:
| Granted 25,000 options to buy
@ $2.62, valued at
$65.5k
|
|
05/21/2010 |
4
| HOFFMANN DAVE (Director) has filed a Form 4 on THRESHOLD PHARMACEUTICALS INC
Txns:
| Granted 12,500 options to buy
@ $1.62, valued at
$20.3k
|
|
06/25/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
05/26/2009 |
4
| HOFFMANN DAVE (Director) has filed a Form 4 on THRESHOLD PHARMACEUTICALS INC |
01/14/2009 |
4
| HOFFMANN DAVE (Director) has filed a Form 4 on THRESHOLD PHARMACEUTICALS INC |
|
|